 Christy Niemeyer
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpes Zoster | 7 | 2024 | 317 | 2.030 |
Why?
| | Herpesvirus 3, Human | 8 | 2024 | 330 | 1.950 |
Why?
| | Amyloid beta-Peptides | 4 | 2024 | 211 | 1.080 |
Why?
| | Microglia | 2 | 2024 | 228 | 0.980 |
Why?
| | Virus Diseases | 3 | 2022 | 209 | 0.970 |
Why?
| | Trigeminal Ganglion | 1 | 2024 | 24 | 0.920 |
Why?
| | Macaca mulatta | 2 | 2024 | 146 | 0.900 |
Why?
| | Trigeminal Neuralgia | 1 | 2024 | 10 | 0.890 |
Why?
| | Herpesviridae Infections | 2 | 2024 | 134 | 0.880 |
Why?
| | Herpes Simplex | 1 | 2024 | 93 | 0.870 |
Why?
| | Neuralgia, Postherpetic | 1 | 2024 | 40 | 0.870 |
Why?
| | Herpesvirus 1, Human | 1 | 2024 | 85 | 0.860 |
Why?
| | Nerve Block | 1 | 2024 | 64 | 0.840 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 129 | 0.790 |
Why?
| | Neuralgia | 1 | 2024 | 119 | 0.780 |
Why?
| | Adrenal Glands | 1 | 2021 | 70 | 0.730 |
Why?
| | Cell Death | 1 | 2022 | 348 | 0.690 |
Why?
| | Varicella Zoster Virus Infection | 3 | 2024 | 25 | 0.580 |
Why?
| | Cytokines | 1 | 2024 | 1983 | 0.500 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5272 | 0.470 |
Why?
| | Virus Activation | 2 | 2024 | 81 | 0.430 |
Why?
| | Varicellovirus | 2 | 2024 | 16 | 0.420 |
Why?
| | Alzheimer Disease | 2 | 2024 | 516 | 0.280 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 64 | 0.270 |
Why?
| | Monkey Diseases | 1 | 2024 | 19 | 0.220 |
Why?
| | Virus Latency | 1 | 2024 | 77 | 0.220 |
Why?
| | Animals | 7 | 2024 | 34479 | 0.220 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 93 | 0.210 |
Why?
| | Central Nervous System | 1 | 2024 | 254 | 0.200 |
Why?
| | Adrenal Cortex | 1 | 2022 | 27 | 0.190 |
Why?
| | Viral Proteins | 1 | 2024 | 321 | 0.190 |
Why?
| | Exanthema | 1 | 2022 | 73 | 0.190 |
Why?
| | Macaca fascicularis | 1 | 2021 | 48 | 0.190 |
Why?
| | Primary Cell Culture | 1 | 2022 | 158 | 0.190 |
Why?
| | Chickenpox | 1 | 2022 | 78 | 0.180 |
Why?
| | Adventitia | 1 | 2021 | 42 | 0.180 |
Why?
| | Histological Techniques | 1 | 2021 | 39 | 0.180 |
Why?
| | Temporal Arteries | 1 | 2021 | 45 | 0.180 |
Why?
| | Giant Cell Arteritis | 1 | 2021 | 47 | 0.180 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 89 | 0.180 |
Why?
| | Antigens, Viral | 1 | 2021 | 174 | 0.180 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 8 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 67 | 0.170 |
Why?
| | Interleukins | 1 | 2022 | 242 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 68 | 0.170 |
Why?
| | Peptide Fragments | 1 | 2024 | 684 | 0.170 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.170 |
Why?
| | Vascular Remodeling | 1 | 2021 | 181 | 0.170 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2020 | 46 | 0.160 |
Why?
| | DNA, Viral | 1 | 2021 | 348 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 90 | 0.160 |
Why?
| | Virus Replication | 1 | 2022 | 444 | 0.160 |
Why?
| | Meningitis | 1 | 2020 | 80 | 0.160 |
Why?
| | Astrocytes | 1 | 2020 | 188 | 0.150 |
Why?
| | Motor Neurons | 1 | 2020 | 238 | 0.140 |
Why?
| | MicroRNAs | 1 | 2024 | 677 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2020 | 703 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1185 | 0.140 |
Why?
| | Macrophages | 1 | 2024 | 1460 | 0.140 |
Why?
| | Fibroblasts | 1 | 2021 | 935 | 0.130 |
Why?
| | Antibodies, Viral | 1 | 2020 | 601 | 0.130 |
Why?
| | Brain | 2 | 2024 | 2620 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 899 | 0.120 |
Why?
| | Stroke | 1 | 2023 | 1063 | 0.110 |
Why?
| | Inflammation | 2 | 2022 | 2654 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2024 | 3937 | 0.110 |
Why?
| | Humans | 11 | 2024 | 128417 | 0.110 |
Why?
| | Mice | 3 | 2024 | 16602 | 0.100 |
Why?
| | Male | 5 | 2024 | 62857 | 0.090 |
Why?
| | Female | 5 | 2024 | 68153 | 0.080 |
Why?
| | Acyclovir | 2 | 2020 | 93 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 429 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2021 | 4001 | 0.080 |
Why?
| | Presenilin-1 | 1 | 2022 | 31 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 209 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.050 |
Why?
| | Tissue Fixation | 1 | 2021 | 33 | 0.050 |
Why?
| | Paraffin Embedding | 1 | 2021 | 27 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 200 | 0.050 |
Why?
| | Formaldehyde | 1 | 2021 | 57 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 466 | 0.050 |
Why?
| | Estrogens | 1 | 2024 | 342 | 0.050 |
Why?
| | Olfactory Bulb | 1 | 2022 | 136 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 70 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 120 | 0.040 |
Why?
| | Thrombosis | 1 | 2023 | 324 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 80 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 229 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 244 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 224 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 468 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 518 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1009 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2071 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 881 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1688 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2731 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 848 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3232 | 0.030 |
Why?
| | Aging | 1 | 2024 | 1750 | 0.030 |
Why?
| | Aged | 2 | 2024 | 21953 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2675 | 0.030 |
Why?
| | Middle Aged | 2 | 2024 | 30889 | 0.020 |
Why?
|
|
Niemeyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|